{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:10:53Z","timestamp":1772507453864,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.leukres.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T15:29:10Z","timestamp":1302881350000},"page":"1330-1334","source":"Crossref","is-referenced-by-count":14,"title":["High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Hans Carl","family":"Hasselbalch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibe","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Stauffer","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Hasselbalch","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Weis","family":"Bjerrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben A.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.03.013_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","article-title":"Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule","volume":"57","author":"Benchimol","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2011.03.013_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/excr.2000.5038","article-title":"Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1","volume":"261","author":"Wagener","year":"2000","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.leukres.2011.03.013_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: their role in physiology and pathophysiology","volume":"18","author":"Kuespert","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"17","key":"10.1016\/j.leukres.2011.03.013_bib0020","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.leukres.2011.03.013_bib0025","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2011.03.013_bib0030","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1182\/blood-2004-08-3238","article-title":"Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2011.03.013_bib0035","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood-2008-06-158386","article-title":"French INSERM and the European EUMNET Networks on Myelofibrosis. Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence","volume":"112","author":"Lataillade","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2011.03.013_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.leukres.2008.06.002","article-title":"Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?","volume":"33","author":"Hasselbalch","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.03.013_bib0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.03.013_bib0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","article-title":"Identification of \u201cshort-lived\u201d and \u201clong-lived\u201d patients at presentation of idiopathic myelofibrosis","volume":"97","author":"Cervantes","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0055","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/cncr.22630","article-title":"Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis base on 334 patients from a single institution","volume":"109","author":"Tefferi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2011.03.013_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0609.1990.tb00419.x","article-title":"Idiopathic myelofibrosis. A review","volume":"45","author":"Hasselbalch","year":"1990","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2307\/1390807","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comp Graph Stat"},{"key":"10.1016\/j.leukres.2011.03.013_bib0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.leukres.2011.03.013_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical Bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"10.1016\/j.leukres.2011.03.013_bib0085","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.174.11.6692","article-title":"Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1","volume":"174","author":"Stern","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.leukres.2011.03.013_bib0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nri1864","article-title":"CEACAM1: contact-dependent control of immunity","volume":"6","author":"Gray-Owen","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.leukres.2011.03.013_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.2010.02237.x","article-title":"Neutrophil granules in health and disease","volume":"268","author":"H\u00e4ger","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.leukres.2011.03.013_bib0100","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1038\/sj.onc.1208259","article-title":"The human tumour suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis","volume":"23","author":"Nittka","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.leukres.2011.03.013_bib0105","first-page":"2260","article-title":"Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer","volume":"9","author":"Sienel","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.leukres.2011.03.013_bib0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.sla.0000154455.86404.e9","article-title":"CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions","volume":"241","author":"Duxbury","year":"2005","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.leukres.2011.03.013_bib0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.lungcan.2007.11.015","article-title":"Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer","volume":"60","author":"Dango","year":"2008","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2011.03.013_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1078-0432.CCR-07-1363","article-title":"Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen","volume":"14","author":"Maraqa","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.leukres.2011.03.013_bib0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/PAI.0b013e318196e13c","article-title":"CEACAM1 expression in pancreatic endocrine tumors","volume":"17","author":"Serra","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.leukres.2011.03.013_bib0130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.2545","article-title":"Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma","volume":"218","author":"Strickland","year":"2009","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.leukres.2011.03.013_bib0135","doi-asserted-by":"crossref","first-page":"e8747","DOI":"10.1371\/journal.pone.0008747","article-title":"Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells","volume":"5","author":"Singer","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.leukres.2011.03.013_bib0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2009.10.056","article-title":"CEACAM-7: a predictive marker for rectal cancer recurrence","volume":"147","author":"Messick","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.leukres.2011.03.013_bib0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.leu.2401408","article-title":"The Kor-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50\/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cells","volume":"13","author":"Sugita","year":"1999","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2011.03.013_bib0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00277-007-0388-1","article-title":"High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias","volume":"87","author":"Lasa","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0155","first-page":"3419","article-title":"Human carcinoembryonic antigen functions as a general inhibitor of anoikis","volume":"60","author":"Ordonez","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.03.013_bib0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.onc.1207036","article-title":"CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells","volume":"23","author":"Duxbury","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2011.03.013_bib0165","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/MCB.26.5.1754-1769.2006","article-title":"The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by ETV6-NTRK3 chimeric tyrosine kinase","volume":"26","author":"Martin","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0170","first-page":"8481","article-title":"CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope","volume":"63","author":"Campi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.03.013_bib0175","first-page":"6","article-title":"Interferon in the treatment of the myeloproliferative disorders","volume":"27","author":"Silver","year":"1990","journal-title":"Semin Hematol"},{"issue":"12","key":"10.1016\/j.leukres.2011.03.013_bib0180","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s002770050554","article-title":"The role of interferon-alpha in the treatment of idiopathic myelofibrosis","volume":"78","author":"Bachleitner-Hofmann","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0185","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1200\/JCO.2009.23.6075","article-title":"Pegylated interferon-alfa-2a therapy yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera","volume":"27","author":"Quintas-Cardama","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.03.013_bib0190","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood-2006-03-009860","article-title":"High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a","volume":"108","author":"Kiladjian","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2011.03.013_bib0195","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","article-title":"Pegylated Interferon-alfa-2a induces complete haematological and molecular responses with low toxicity in polycythemia vera","volume":"112","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2011.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/leu.2008.280","article-title":"Interferon-alpha therapy in bcr-abl-negative myeloproliferative neoplasms","volume":"22","author":"Kiladjian","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2011.03.013_bib0205","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00277-008-0498-4","article-title":"Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera","volume":"87","author":"Larsen","year":"2008","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.leukres.2011.03.013_bib0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/102453309X12473408860587","article-title":"Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete haematological remission","volume":"14","author":"Larsen","year":"2009","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.leukres.2011.03.013_bib0215","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/leu.2009.90","article-title":"Recombinant interferon alpha(rIFN-alpha-2b) may retard progression of early myelofibrosis","volume":"23","author":"Silver","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.03.013_bib0220","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2141.2009.07745.x","article-title":"PEG-IFN-2a therapy in patients with myelofibrosis. A study of the French Groupe d\u2019Etudes des Myelofibroses (GEM) and France Intergroupe des syndromes Myeloproliferatifs (FIM)","volume":"146","author":"Ianotto","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:11:29Z","timestamp":1741144289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0145212611001299"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.03.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}